A potential reduction in both OPG and RANKL serum levels after atorvastatin treatment was previously shown by Dimitrow and coworkers in patients with aortic sclerosis or mild aortic stenosis [22]. The gene discussed is TNFSF11; the disease is aortic stenosis.